BioSpace4d
FDA, Other Experts Seek to Redefine Obesity and Prioritize Maintenance Treatment
Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...
Fierce Pharma3d
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in
As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Medscape5d
Drug Labels Often Neglect to Inform About Obesity Dosing
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
Audacy on MSN2d
Minnesota state lawmakers renew push to require insurance coverage of anti-obesity drugs
Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy ...
EurekAlert!11d
The Obesity Society commends FDA's resolution of obesity drug shortages, calls for enforcement against unauthorized compounding
ROCKVILLE, MD – The Obesity Society (TOS) acknowledges the U.S. Food and Drug Administration's (FDA) recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and Ozempic; two ...
Zacks Investment Research on MSN1d
Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More
Bayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm ...
BioSpace4d
Tariff Threat Continues, More Meetings Cancelled, AbbVie Makes Obesity Play, More
Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...
Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs
Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...